Top

Published in:

01-10-2006 | Abstracts

ABSTRACTS: ISoP Annual Conference ‘Joining Forces for Managing Risks’ Liège, Belgium 11–13 October, 2006

Authors: J. J. de Langen-Wouterse, E. P. van Puijenbroek, A. C. van Grootheest

Published in: Drug Safety | Issue 10/2006

Excerpt

Introduction: The use of selective serotonin reuptake inhibitors (SSRIs) is growing. SSRIs are indicated for depression, obsessive-compulsive disorders, bulimia nervosa, panic disorders, anxiety and post-traumatic stress disorder. They inhibit the presynaptic reuptake of serotonin in the neurons. Possible adverse drug reactions (ADRs) are gastrointestinal complaints, headache, dizziness, dry mouth and sleep disorders. …

Hamel H, et al. Chronic cough under treatment with paroxetine. Presse Med 2000; 29: 1045PubMed

Spigset O. Adverse reactions of selective serotonin reuptake inhibitors: reports from a spontaneous reporting system. Drug Saf 1999

Thurmann PA, et al. Influence of gender on the pharmacokinetics and pharmacodynamics of drugs. Int J Clin Pharmacol Ther 1998; 36: 586–90PubMed

Title: ABSTRACTS: ISoP Annual Conference ‘Joining Forces for Managing Risks’ Liège, Belgium 11–13 October, 2006
Authors: J. J. de Langen-Wouterse
E. P. van Puijenbroek
A. C. van Grootheest
Publication date: 01-10-2006
Publisher: Springer International Publishing
Published in: Drug Safety / Issue 10/2006
Print ISSN: 0114-5916
Electronic ISSN: 1179-1942
DOI: https://doi.org/10.2165/00002018-200629100-00161

Keynote webinar | Spotlight on medication adherence

Springer Medicine

ABSTRACTS: ISoP Annual Conference ‘Joining Forces for Managing Risks’ Liège, Belgium 11–13 October, 2006

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 10/2006